Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Leonardo Biosystems and NanoMedical Systems Sign Collaboration Deal for Manufacturing Scale Up of Leonardo's Drug Delivery Nanoparticles

Abstract:
Leonardo Biosystems, Inc. and NanoMedical Systems, Inc. (NMS), two emerging drug delivery companies, today announced that they have signed a development contract in which NMS will develop and establish a commercial process to manufacture nanoporous silicon particles for Leonardo's multi-stage drug delivery system.
"The expertise in the fabrication of massively-parallel nanofluidic structures in silicon gained in the development of our own drug delivery products enables us to support Leonardo in bringing their manufacturing process to a commercial performance level," said Randy Goodall, President and CEO of NanoMedical Systems. "Our medical device engineering quality system is designed to produce an FDA-compliant process that will bring Leonardo to the doorstep of clinical testing of their innovative drug delivery products."

Leonardo Biosystems and NanoMedical Systems Sign Collaboration Deal for Manufacturing Scale Up of Leonardo's Drug Delivery Nanoparticles

Houston and Austin, TX | Posted on November 28th, 2011

With the support of university researchers and NMS, Leonardo has formed prototype particles, demonstrating all the necessary unit processes to make the particles. Under the collaboration, NMS will engineer, refine, and integrate these steps in a manner that prepares Leonardo for manufacturing particles suitable for clinical trials.

"NMS's familiarity with silicon materials and their capability to do the work under an FDA-compliant quality system makes them an ideal partner," said Bruce D. Given, M.D., CEO of Leonardo Biosystems. "Creation of a commercial-scale manufacturing process compliant with regulatory requirements is on the critical path for Leonardo to translate its exciting animal proof of concept data into clinical reality. With NMS as a partner, we look forward to moving ahead aggressively with our development program."

####

About Arrowhead Research Corporation
About Leonardo's multi-stage system
Leonardo's lead technology consists of fully biodegradable, porous silicon particles smaller than a red blood cell, which can be loaded with a diverse array of secondary nanoparticles such as liposomes, micelles, carbon nanotubes, dendrimers and metallic nanoparticles. In addition to bypassing many of the body's natural defenses that lead to rapid clearance of nanoparticles administered alone, Leonardo's particles can be designed to seek out tumor vasculature and can be tuned to create an intravascular depot, providing sustained release following a single intravenous injection.


About Leonardo Biosystems, Inc.
Leonardo Biosystems is a drug delivery company built around technology developed by Dr. Mauro Ferrari, one of the world's best-known nano-science innovators. Leonardo has a multi-stage delivery platform that has been shown in animal models to be highly effective in targeting delivery of siRNA and small molecule drugs. Leonardo is a portfolio company of Arrowhead Research Corporation (NASDAQ: ARWR, NASDAQ: ARWRD). For more information, please visit www.leonardobiosystems.com.

About NanoMedical Systems, Inc.

NanoMedical Systems is a privately held, drug delivery company developing implantable devices that use silicon nanochannel technology invented by Dr. Mauro Ferrari, an original innovator in the field of Bio-MEMS. NanoMedical Systems implant platform, the Personalized Molecular Drug-delivery System includes a first generation device (PMDS-1) customizable for months of constant release of a wide range of drug and biologic molecules with a second generation device (PMDS-2) that will provide variable controlled release via programming, remote control, and sensors. The PMDS-1 has demonstrated the sustained delivery of therapeutics from small molecules to peptides and proteins in both in vitro and in vivo studies. For more information, please visit www.NanoMedSys.com.

For more information, please click here

Contacts:
Investor Relations Contact:
Brandi Floberg or Kathy Price
The Piacente Group, Inc.
212-481-2050

Copyright © Arrowhead Research Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Chitosan coated, chemotherapy packed nanoparticles may target cancer stem cells June 30th, 2015

BASF and Fraunhofer IPMS-CNT jointly develop electronic materials June 30th, 2015

Researchers from the UCA, key players in a pioneering study that may explain the origin of several digestive diseases June 30th, 2015

Oxford Instrumentsí TritonXL Cryofree dilution refrigerator selected for the Oxford NQIT Quantum Technology Hub project June 30th, 2015

Microfluidics/Nanofluidics

Lehigh University researchers unveil engineering innovations at TechConnect 2015: TechConnect is the world's largest accelerator for industry-vetted emerging-technologies ready for commercialization June 11th, 2015

How to cut a vortex into slices: A group of physicists, lead by Olga Vinogradova, professor at the Lomonosov Moscow State University, came up with a way to stir up a liquid in the microchannel June 3rd, 2015

What makes cancer cells spread? New device offers clues May 19th, 2015

Microchip captures clusters of circulating tumor cells -- NIH study May 18th, 2015

Nanotubes/Buckyballs/Fullerenes

Cellulose from wood can be printed in 3-D June 17th, 2015

Researchers grind nanotubes to get nanoribbons: Rice-led experiments demonstrate solid-state carbon nanotube 'templates' June 15th, 2015

Environmental Issues to Hamper Growth of Global Nanocomposites Market June 4th, 2015

Carbon Nanotubes (CNT) Market Trends, Segments And Forecasts To 2022: Grand View Research, Inc June 1st, 2015

Nanomedicine

Chitosan coated, chemotherapy packed nanoparticles may target cancer stem cells June 30th, 2015

Researchers from the UCA, key players in a pioneering study that may explain the origin of several digestive diseases June 30th, 2015

Efforts to Use Smart Nanocarriers to Cure Leukemia Yield Promising Results June 29th, 2015

Chivalrous Knight Does Pro Bono June 27th, 2015

Announcements

BASF and Fraunhofer IPMS-CNT jointly develop electronic materials June 30th, 2015

Graphene flexes its electronic muscles: Rice-led researchers calculate electrical properties of carbon cones, other shapes June 30th, 2015

Researchers from the UCA, key players in a pioneering study that may explain the origin of several digestive diseases June 30th, 2015

Oxford Instrumentsí TritonXL Cryofree dilution refrigerator selected for the Oxford NQIT Quantum Technology Hub project June 30th, 2015

Alliances/Trade associations/Partnerships/Distributorships

Graphene breakthrough as Bosch creates magnetic sensor 100 times more sensitive than silicon equivalent June 28th, 2015

Dyesol Joins Solliance as an Industrial Partner June 17th, 2015

Framework materials yield to pressure June 11th, 2015

The European project SVARNISH, a step forward in the food packaging sector June 11th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project